Page last updated: 2024-11-03

procarbazine and Leukemia, Acute Monocytic

procarbazine has been researched along with Leukemia, Acute Monocytic in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research Excerpts

ExcerptRelevanceReference
"2) Non-Hodgkin's lymphoma has not appeared in any of the patients in this series."1.28[Second neoplasms as a late complication of the treatment of Hodgkin's disease]. ( Alvarez, A; Colomé, JA; del Potro, E; Díaz Mediavilla, J; González, FA; Martínez, R; Morales, MD; Villegas, A, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morales, MD1
González, FA1
Villegas, A1
del Potro, E1
Díaz Mediavilla, J1
Martínez, R1
Alvarez, A1
Colomé, JA1

Other Studies

1 other study available for procarbazine and Leukemia, Acute Monocytic

ArticleYear
[Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Sangre, 1992, Volume: 37, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinom

1992